At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 620 enrolled
Drug / intervention
menotropin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Assessor-blind Trial Comparing MENOPUR® (Menotropins for Injection) and Recombinant FSH (Follicle Stimulating Hormone) in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
In Brief
A Phase 4 clinical trial evaluating menotropin and recombinant FSH for Infertility. Completed, enrolled 620 participants across 35 sites.
Detailed Summary
The purpose of this trial is to demonstrate non-inferiority of MENOPUR® versus recombinant Follicle Stimulating Hormone (rFSH) (Gonal-f®) with respect to ongoing pregnancy rate in women undergoing controlled ovarian stimulation (COS) following GnRH treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartAug 2015
First PostedSep 2015
Primary CompletionJan 2017
Study CompletionFeb 2017
TodayJul 2026
First PostedSep 18, 2015
Enrollment StartAug 31, 2015
Primary CompletionJan 26, 2017
Study CompletionFeb 2, 2017
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.8 years ago
Interventions
menotropindrug
recombinant FSHdrug